Linezolid Dr. Eberth

Linezolid, the active ingredient in Linezolid Dr. Eberth, is a oxazolidinone antibiotic presented as a 600 mg tablet for oral use. It treats infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus and vancomycin‑resistant Enterococcus, in adult patients requiring systemic therapy.

GNH USA supplies Linezolid Dr. Eberth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

- Complicated skin and skin structure infections (cSSSI): effective against MRSA and other resistant Gram‑positive pathogens, leading to clinical cure. - Community‑acquired bacterial pneumonia (CABP): provides coverage for suspected MRSA involvement in adult patients. - Ventilator‑associated bacterial pneumonia (VABP): indicated for treatment of Gram‑positive infections in mechanically ventilated patients.

Linezolid may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste sensation during therapy.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count, requiring monitoring. - Peripheral neuropathy: sensory changes that may become irreversible with prolonged use. - Serotonin syndrome: risk when combined with serotonergic agents, presenting with agitation, hyperreflexia, and fever.

When prescribing Linezolid, clinicians should consider several safety aspects to minimize risk.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution; assess liver enzymes regularly. - Concomitant serotonergic drugs: avoid due to potential serotonin syndrome. - Myelosuppression: perform baseline and periodic complete blood counts. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks to fetus or infant. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several drug classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - SSRIs, SNRIs, and other serotonergic agents: may precipitate serotonin syndrome. - MAO inhibitors: increase risk of hypertensive crisis. - Tyramine‑rich foods (e.g., aged cheeses, cured meats): can cause hypertensive episodes.

Moderate Interactions (Monitor Closely): - Warfarin: linezolid may potentiate anticoagulant effect, requiring INR monitoring. - Phenytoin: may reduce linezolid plasma concentrations, potentially decreasing efficacy. - Rifampin: induces metabolism leading to lower linezolid exposure, may need dose adjustment.